Procaps Group S.A. - Utang jangka cendhak perusahaan PROC

Logo perusahaan publik Procaps (PROC)

Procaps Group S.A. (PROC) is a global manufacturer of softgels operating under the CDMO model. The asset's market dynamics reflect the impact of stable cash flow and high operating profit, with the indicator standing at 0.00. Dominance in the Latin American market and innovative drug delivery methods allow the company to exercise effective pricing power. Meanwhile, long-term agreements with major brands constrain excessive price increases.

PROC (Procaps Group) riwayat Utang jangka cendhak perusahaan saka 04.07.2022 nganti 16.02.2025
Produk dadi procapsgroup.com

Stable demand for contract capsule manufacturing for Procaps Group S.A. minimizes liquidity risks, making the current value of 0.00 an indicator of managed development. By analyzing the dynamics of short-term credit obligations, an investor assesses the volume of debt maturing within one year, which allows them to filter out market noise and determine the company's actual ability to service operational debts without compromising capital.

Pesaing Procaps Group S.A. (PROC)

Utang jangka cendhak perusahaan Haleon (HLN)|KVUE: Silihan lan utang jangka cendhak perusahaan|VRNA (Verona Pharma Corp) - Utang jangka cendhak perusahaan|Jyong Bio (MENS) - Kewajiban jangka cendhak perusahaan|LGND (Ligand Pharmaceuticals) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan amneal.com (AMRX)|Perrigo (PRGO) - Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan ALVO (Alvotech S.A.)|LQDA: Utang jangka cendhak perusahaan|GLPG - Utang jangka cendhak|Kewajiban jangka cendhak perusahaan ANI Pharmaceuticals ANIP|MNKD - Gedhene kewajiban jangka cendhak|Utang jangka cendhak perusahaan Amphastar Pharmaceuticals, Inc. AMPH|Pacira Pharmaceuticals (PCRX) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan SPRY (ARS Pharma)|Utang jangka cendhak TBPH|Aquestive Therapeutics (AQST) - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan SCPH (scpharmaceuticals.com)|Tectonic Therapeutic (TECX) - Utang jangka cendhak perusahaan|Tonix Pharma - Kewajiban jangka cendhak|Utang jangka cendhak perusahaan SXT China (SXTC)|EPRX: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan BHST|invizyne.com (EXOZ) - Utang jangka cendhak|Utang jangka cendhak perusahaan ORMP|Kewajiban jangka cendhak perusahaan Entera Bio Corp|Utang jangka cendhak perusahaan HYFT|Utang jangka cendhak perusahaan ABVC (ABVC BioPharma, Inc)|Cumberland Pharmaceuticals (CPIX) - Utang jangka cendhak perusahaan|quantumbiopharma.com - Kewajiban jangka cendhak|Utang jangka cendhak perusahaan FGEN (FibroGen)|Telomir Pharmaceuticals Inc (TELO) - Gunggunge utang jangka cendhak|Kewajiban jangka cendhak perusahaan ranitherapeutics.com RANI|Synergy CHC (SNYR) - Silihan lan utang jangka cendhak perusahaan|Rallybio Corp - Utang jangka cendhak perusahaan|Tanggungan jangka cendhak LEXX|Pulmatrix (PULM) - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan PTHL (ftzy.com.cn)|APM: Utang jangka cendhak perusahaan|LYRA - Utang jangka cendhak|Impact BioMedical - Kewajiban jangka cendhak perusahaan|TNFA: Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan cbdmd.com (YCBD)|Kewajiban jangka cendhak PainReform Ltd|CYTO - Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan LIPO|OPTN (OptiNose, Inc.) - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak pieris.com PIRS|Kewajiban jangka cendhak perusahaan PTPI|Gunggunge utang jangka cendhak Qilian International Holding Group QLI|ACELYRIN, Inc. - Utang jangka cendhak perusahaan|TFF Pharmaceuticals, Inc (TFFP) - Utang jangka cendhak perusahaan